Picture of Aceragen logo

ACGN — Aceragen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Brief: Idera Pharmaceuticals Reports Q1 Loss Per Share $0.40

May 2 (Reuters) - Idera Pharmaceuticals Inc  IDRA.O :
    * IDERA PHARMACEUTICALS REPORTS FIRST QUARTER 2019 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * Q1 LOSS PER SHARE $0.40
    * Q1 EARNINGS PER SHARE ESTIMATE $-0.46 -- REFINITIV IBES
DATA
    * IDERA PHARMACEUTICALS - AS OF MARCH 31, 2019, OUR CASH,
CASH
EQUIVALENTS AND INVESTMENTS TOTALED $59.9 MILLION COMPARED TO
$71.4 MILLION AS OF DECEMBER 31, 2018

Source text for Eikon:  ID:nGNX1BWXs5 
Further company coverage:  IDRA.O 

 (Reuters.Briefs@thomsonreuters.com)

Recent news on Aceragen

See all news